High selectivity of PI3Kβ inhibitors in SETD2-mutated renal clear cell carcinoma
{{output}}
Purpose: Clear cell renal cell carcinoma (ccRCC) is characterized with frequent mutations of SETD2 gene and our purpose was to explore targeted therapy for this entity. ... ...
